Synonyms CD158 antigen-like family member Z, CD158Z, killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 3 + [6] |
Introduction Receptor on natural killer cells. May inhibit the activity of NK cells thus preventing cell lysis. |
Target |
Mechanism KIR3DL3 inhibitors |
Active Org. Nextpoint Therapeutics, Inc.Startup |
Originator Org. Nextpoint Therapeutics, Inc.Startup |
Active Indication |
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Target |
Mechanism KIR3DL3 inhibitors |
Active Org. Nextpoint Therapeutics, Inc.Startup |
Originator Org. Nextpoint Therapeutics, Inc.Startup |
Active Indication |
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Start Date21 Jul 2023 |
Sponsor / Collaborator Nextpoint Therapeutics, Inc.Startup |